- Home
- IVDA vs MYNZ Comparison
IVDA vs MYNZ Comparison
Compare IVDA & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVDA
- MYNZ
- Stock Information
- Founded
- IVDA 2003
- MYNZ 2021
- Country
- IVDA United States
- MYNZ Germany
- Employees
- IVDA N/A
- MYNZ N/A
- Industry
- IVDA Computer Software: Prepackaged Software
- MYNZ Biotechnology: Pharmaceutical Preparations
- Sector
- IVDA Technology
- MYNZ Health Care
- Exchange
- IVDA Nasdaq
- MYNZ Nasdaq
- Market Cap
- IVDA 6.7M
- MYNZ 5.5M
- IPO Year
- IVDA N/A
- MYNZ 2021
- Fundamental
- Price
- IVDA $2.19
- MYNZ $1.92
- Analyst Decision
- IVDA
- MYNZ Buy
- Analyst Count
- IVDA 0
- MYNZ 2
- Target Price
- IVDA N/A
- MYNZ $14.00
- AVG Volume (30 Days)
- IVDA 78.5K
- MYNZ 154.3K
- Earning Date
- IVDA 08-13-2025
- MYNZ 07-22-2025
- Dividend Yield
- IVDA N/A
- MYNZ N/A
- EPS Growth
- IVDA N/A
- MYNZ N/A
- EPS
- IVDA N/A
- MYNZ N/A
- Revenue
- IVDA $7,148,449.00
- MYNZ $893,991.00
- Revenue This Year
- IVDA $340.48
- MYNZ $26.06
- Revenue Next Year
- IVDA N/A
- MYNZ $4.97
- P/E Ratio
- IVDA N/A
- MYNZ N/A
- Revenue Growth
- IVDA 54.15
- MYNZ N/A
- 52 Week Low
- IVDA $1.27
- MYNZ $1.34
- 52 Week High
- IVDA $8.05
- MYNZ $20.08
- Technical
- Relative Strength Index (RSI)
- IVDA 51.25
- MYNZ 57.87
- Support Level
- IVDA $1.76
- MYNZ $1.35
- Resistance Level
- IVDA $2.44
- MYNZ $2.15
- Average True Range (ATR)
- IVDA 0.18
- MYNZ 0.13
- MACD
- IVDA 0.04
- MYNZ 0.10
- Stochastic Oscillator
- IVDA 57.53
- MYNZ 71.67
About IVDA Iveda Solutions Inc.
Iveda Solutions Inc offers smart city technologies globally, offering advanced AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients worldwide. The smart cities market, as well as the AI and IoT segments, are poised for significant growth in the coming years. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products).
About MYNZ Mainz Biomed N.V.
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.